Christoph Fraune, Luisa Harms, Franziska Büscheck, Doris Höflmayer, Maria Christina Tsourlakis, Till S. Clauditz, . . . Cornelia Schroeder. (2020). Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2: ERG fusion. BMC.
Chicago Style (17th ed.) CitationChristoph Fraune, et al. Upregulation of the Transcription Factor TFAP2D Is Associated with Aggressive Tumor Phenotype in Prostate Cancer Lacking the TMPRSS2: ERG Fusion. BMC, 2020.
MLA (9th ed.) CitationChristoph Fraune, et al. Upregulation of the Transcription Factor TFAP2D Is Associated with Aggressive Tumor Phenotype in Prostate Cancer Lacking the TMPRSS2: ERG Fusion. BMC, 2020.
Warning: These citations may not always be 100% accurate.